Search
-
How health providers and institutions can align with public priorities
Public health institutions can find common ground by understanding what the public wants from their research, says Ipsos Public Affairs’ Mallory Newall.
-
Why the menopause revolution should matter to businesses and policymakers
The $600 billion menopause market is booming. The Menopause Society’s Dr. Monica Christmas explores why businesses and policymakers can't afford to ignore this long-overlooked health transition affecting millions of women.
-
Why treating menopause matters for the future of women’s health
Ipsos' Abigail Jones explains how brands can understand the growing but unmet needs of menopausal women to build trust and develop better products.
-
Why doctors and engineers are teaming up to make aging better
Johns Hopkins University is building a cross-disciplinary approach to eldercare, integrating AI and tech innovations. Dr. Peter Abadir explains the model and who will fund it as government cuts health research spending.
-
How understanding barriers to early treatment can transform healthcare
Even with scientific breakthroughs, convincing patients to get care is the next great challenge. Ipsos’ Hannah Brown explains how best practices research can help practitioners shift patient attitudes from fear to empowerment.
-
Questions for the future
From an aging population to artificial intelligence, these are the crucial health and wellness questions that leaders in public health, women’s health, technology, aging and consumer health need to consider to prepare for the future.
-
What the Future: American Dream
Hear more about how “Made in America” matters and how to leverage it effectively, and how to tap the nuances of the American Dream across different demographics to tailor your products, innovation pipeline and your messages.
-
[WEBINAR] What the Future: Wellness
The pursuit of wellness influences every aspect of American life. But that picture is changing faster than ever before.
-
The End of the Beginning: The Evolving Landscape of Alzheimer’s Disease Pharmacotherapy
Read more about the recent breakthroughs, ongoing challenges, and future directions of Alzheimer’s disease pharmacotherapy.
-
Three in four Americans say anti-smoking ads are important
Findings of a new Ipsos poll offered exclusively to Axios on the importance of anti-smoking campaigns and whether Americans feel these campaigns should be strengthened or weakened